Pipothiazine palmitate in the long-term treatment of schizophrenia

Fifty patients suffering from active schizophrenic episodes were treated with electroplexy and thioproperazine for 3 weeks. Pipothiazine palmitate was then given parenterally at a dose of 100 mg at 4-week intervals over a period of 3 years. It seemed to be effective in maintaining remissions in forty-eight patients.